Table 7. Exploratory analysis.
| Proportion of patients with a malaria diagnosis among those with a negative diagnostic test result for malaria | Proportion of patients with a malaria diagnosis among those with a positive diagnostic test result for malaria | Proportion of patients with a positive diagnostic test result for malaria among those with a malaria diagnosis | ||||
| Sub groups | Under 5 | 5 and above | Under 5 | 5 and above | Under 5 | 5 and above |
| Part I: Percentage | ||||||
| Arm A | ||||||
| Time 0 | 1,390 (41%) | 2,571 (31%) | 4,865 (82%) | 4,515 (81%) | 4,865 (30%) | 4,515 (15%) |
| Time 1 | 3,154 (29%) | 6,627 (22%) | 14,503 (94%) | 15,209 (92%) | 14,503 (42%) | 15,209 (27%) |
| % Change | −12% | −9% | 11% | 11% | 13% | 12% |
| Arm B | ||||||
| Time 0 | 4,317 (52%) | 6,080 (38%) | 8,605 (79%) | 8,202 (82%) | 8,605 (22%) | 8,202 (14%) |
| Time 1 | 5,545 (53%) | 8,778 (41%) | 8,837 (85%) | 8,726 (89%) | 8,837 (23%) | 8,726 (12%) |
| % Change | 1% | 3% | 5% | 7% | 1% | −2% |
| Part II: Regression | aRR (CI) | p-value | aRR (CI) | p-value | aRR (CI) | p-value |
| Arm A: T1 – T0 | 0.65 (0.40, 1.05) | 0.020 | 1.03 (0.93, 1.13) | 0.496 | 1.34 (0.92, 1.95) | 0.048 |
| Arm B: T1 – T0 | 1.01 (0.90, 1.13) | 0.860 | 1.01 (0.94, 1.09) | 0.651 | 0.88 (0.63, 1.22) | 0.305 |
| Arm A vs. Arm B: | ||||||
| T1-T0 (aRRR) | 0.65 (0.40, 1.05) | 0.021 | 1.01 (0.90, 1.14) | 0.758 | 1.52 (0.96, 2.42) | 0.019 |
| Covariates | ||||||
| Age (1 = Under 5) | 1.34* (1.23, 1.45) | <0.001 | 0.99 (0.96, 1.02) | 0.386 | 1.50* (1.23, 1.84) | <0.001 |
| Facility level (1 = Hospital) | 1.20 (0.76, 1.90) | 0.293 | 1.01 (0.92, 1.10) | 0.814 | 1.13 (0.39, 3.29) | 0.776 |
| Facility type (1 = PNFP) | 1.01 (0.38, 2.67) | 0.978 | 1.02 (0.93, 1.13) | 0.525 | 2.40 (0.64, 9.05) | 0.090 |
| Pediatric HIV support | 0.76 (0.48, 1.21) | 0.129 | 0.90* (0.82, 0.99) | 0.006 | 0.85 (0.47, 1.54) | 0.487 |
| CQI experience | 1.57 (0.84, 2.92) | 0.064 | 0.99 (0.92, 1.06) | 0.635 | 0.67 (0.39, 1.16) | 0.062 |
| DEA stationed | 1.09 (0.92, 1.29) | 0.199 | 1.14* (1.03, 1.25) | 0.001 | 1.23 (0.97, 1.55) | 0.025 |
| EIR (ref: very low/no prevalence) | ||||||
| Low | 1.20 (0.40, 3.59) | 0.668 | 1.12 (0.90, 1.40) | 0.170 | 2.52 (0.35, 18.15) | 0.228 |
| Medium – High | 1.05 (0.40, 2.71) | 0.902 | 1.06 (0.86, 1.31) | 0.444 | 4.30 (0.62, 29.66) | 0.052 |
| Very high | 0.95 (0.39, 2.33) | 0.892 | 1.08 (0.89, 1.33) | 0.299 | 4.01 (0.60, 26.96) | 0.060 |
| Ideal clinical staff ratio quartile (ref: lowest) | ||||||
| 2nd | 1.15 (0.69, 1.93) | 0.468 | 1.05 (0.97, 1.13) | 0.100 | 1.04 (0.57, 1.90) | 0.855 |
| 3rd | 1.01 (0.48, 2.11) | 0.973 | 1.04 (0.96, 1.14) | 0.213 | 0.42* (0.18, 0.99) | 0.009 |
| Highest | 1.12 (0.43, 2.91) | 0.757 | 1.05 (0.98, 1.12) | 0.086 | 1.22 (0.62, 2.39) | 0.449 |
| Clinically active staff quartile (ref: lowest) | ||||||
| 2nd | 0.85 (0.67, 1.08) | 0.077 | 1.02 (0.96, 1.07) | 0.454 | 0.98 (0.69, 1.40) | 0.892 |
| 3rd | 0.90 (0.71, 1.14) | 0.245 | 1.01 (0.97, 1.06) | 0.496 | 1.05 (0.73, 1.51) | 0.735 |
| Highest | 1.01 (0.77, 1.34) | 0.900 | 0.99 (0.93, 1.04) | 0.526 | 1.23 (0.74, 2.03) | 0.289 |
| Lab staff quartile (ref: lowest) | ||||||
| 2nd | 1.44 (0.76, 2.73) | 0.143 | 0.94 (0.83, 1.07) | 0.203 | 0.79 (0.50, 1.25) | 0.186 |
| 3rd | 1.36 (0.71, 2.63) | 0.226 | 0.99 (0.90, 1.09) | 0.740 | 0.80 (0.46, 1.39) | 0.303 |
| Highest | 1.28 (0.30, 5.57) | 0.660 | 0.98 (0.85, 1.14) | 0.725 | 0.50 (0.16, 1.55) | 0.114 |
p<0.01.